Informazioni sul prodotto
O 1812 is a cannabinoid receptor antagonist. It blocks the binding of cannabinoids to their receptors, thereby inhibiting the effects of cannabinoids. O 1812 has been shown to have therapeutic potential in treating kidney disease, bone growth, and cardiovascular disorders. This drug can also be used in cancer therapy and Alzheimer's disease treatment due to its ability to modulate the activity of certain receptors. O 1812 is a programmable compound that can be configured for specific purposes by adding or removing functional groups from the molecule. The addition of an alkoxy radical group at one end of the molecule allows it to be used as an endpoint marker for DNA sequencing reactions because it fluoresces when excited with ultraviolet light.
Proprietà chimiche
Richiesta tecnica su: 3D-CO175166 O 1812
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
